Status:
UNKNOWN
Endovascular Treatment of Popliteal Artery - Balloon Angioplasty Versus Primary Stenting
Lead Sponsor:
Herz-Zentrums Bad Krozingen
Collaborating Sponsors:
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Popliteal Artery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
1. Does primary stenting have a lower 12-month restenosis rate than PTA alone in the treatment of atherosclerotic lesions of the popliteal artery? * Alternative hypothesis: "Primary stenting with ...
Eligibility Criteria
Inclusion
- The patient is at least 21 years old
- The patient or legal representative provided written informed consent
- The patient agrees to comply with the protocol-mandated follow-up visits and testing regime
- The patient has lifestyle-limiting claudication or critical limb ischemia defined as: Fontaine stage IIa-IV/ Rutherford 1-5 category
- The target lesion located within the popliteal artery has angiographic evidence of stenosis \> 70% or occlusion (by visual estimate)
- At least one vessel runoff to the foot
- The patient has no other relevant inflow or outflow stenosis (\> 50%), however when needed iliac or femoral intervention may be done during study procedure.
Exclusion
- The patient is currently participating in a drug or another device study.
- The popliteal artery target lesion has previously been subintimal recanalized
- The patient has a history of bleeding diatheses or coagulopathy
- Female patients that are pregnant
- The patient has a contraindication (including allergic reaction) to platelet aggregation inhibitors or heparin
- The patient is unable to conform to the study protocol follow-up procedures or visits.
- The patient has a life expectancy of \<24 months
- The patient has concomitant renal failure which requires dialysis
- The patient has a contraindication (including allergic reaction) to or a known sensitivity to contrast media
- The duplex ultrasound/angiography of the target lesion must NOT meet the following criteria:
- The popliteal artery target lesion stenosis/occlusion is also continuously located within the superficial femoral artery and/or tibiofibular tract
- The popliteal artery target lesion is restenotic
- The popliteal artery has been subintimal recanalized
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00712309
Start Date
February 1 2007
Last Update
February 10 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Herzzentrum Bad Krozingen
Bad Krozingen, Germany, 79189
2
Universitäres Herzzentrum Hamburg
Hamburg, Germany, 22527